CEO Shaw to leave Ambri
Monday, 24 March, 2003
Dr Joe Shaw, the managing director and CEO of Sydney-based biosensor specialist Ambri (ASX: ABI), has resigned from the company and will return to the US.
He will be replaced at the helm by non-executive director David Cornelius until a new, permanent CEO can be found. Cornelius is on secondment from his position as executive director of Ambri partner Dow Corning's new ventures division.
Shaw, who joined the company almost four years ago, had helped usher in "substantial progress towards commercialisation" of Ambri's biosensor technology, said company chairman Dr John Eady in a statement.
He said Cornelius, with the help of new COO Dr Jonathan Wright, would "provide new and valuable skills and experience needed to lead Ambri through the next phases pf its development."
Shaw said he expected to return to the US at Easter but said he would not comment further at this time. Cornelius was not available for comment by press time.
Prenatal stress leaves a molecular mark on newborns
An international study has uncovered how stress experienced during pregnancy can affect newborns...
More effective antibiotic found for Lyme disease
Researchers have found that piperacillin, an antibiotic in the same class as penicillin,...
Why do our waistlines expand in middle age?
A new preclinical study highlights the importance of controlling new fat-cell formation to...
